Camptothecins in Cancer Therapy
Clinical interest in the camptothecins continues to expand even though this class of topoisomerase I inhibitors has been studied for almost 50 years, and two early generation members of the family have gained FDA approval. In Camptothecins in Cancer Therapy, leading clinicians and researchers critic...
| Corporate Author: | SpringerLink (Online service) |
|---|---|
| Other Authors: | Adams, Val R. (Editor), Burke, Thomas G. (Editor) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Totowa, NJ :
Humana Press,
2005.
|
| Series: | Cancer Drug Discovery and Development
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Similar Items
-
Combination Cancer Therapy Modulators and Potentiators /
Published: (2005) -
Intraperitoneal Cancer Therapy
Published: (2007) -
Death Receptors in Cancer Therapy
Published: (2005) -
Supportive Care in Cancer Therapy
Published: (2009) -
In Vivo Imaging of Cancer Therapy
Published: (2007)